Society | May 11

Third coronavirus drug approved for use in Japan

Japan's health ministry has approved the use of a rheumatoid arthritis drug, baricitinib, for treating COVID-19 patients. It's the third coronavirus drug to be approved in the country, following remdesivir and dexamethasone.

Baricitinib helps subdue inflammation resulting from immune disorders. It is already used to treat rheumatoid arthritis and atopic dermatitis.

In November last year, the US Food and Drug Administration granted an emergency use approval for the drug in combination with antiviral drug remdesivir to treat COVID-19 patients.

Eli Lilly Japan, which manufactures and sells the drug in the country, told an online news conference on Monday that baricitinib has already been administered to more than 200,000 COVID-19 patients around the world.

The firm said it hopes the drug will be used to treat between 4,500 to 6,000 people in Japan by the end of March next year.

Only adult patients who need supplemental oxygen because of pneumonia are eligible to receive the drug. It will be used in combination with the antiviral drug remdesivir, and will be administered once a day.

The drug is not approved for pregnant women.

Eli Lilly Japan says using baricitinib along with remdesivir speeded up recovery by one day on average in international clinical tests, compared with the remdesivir-only control group.


MORE Society NEWS

A fire chief in Shiga Prefecture has been disciplined for "vaccine harassment," after a staff member who chose not to receive the COVID-19 jab was made to work in the office hallway.

Last year saw a record-breaking 1,963 prohibition orders issued in Japan under the Stalking Control Law, marking the highest number to date.

Currently, there's a rapid increase in individuals suffering from "spring fatigue." You might be affected without even realizing it.

POPULAR NEWS

Japan's Meteorological Agency announced the blooming of the Somei Yoshino cherry blossoms in Tokyo at 2 p.m. on Friday, five days later than average.

JAXA has announced the revival of the unmanned explorer "SLIM" following its successful hibernation after making Japan's first moon landing. The probe successfully endured a second lunar night, a period during which temperatures can drop to as low as minus 170 degrees Celsius.

As more people keep pets indoors, there has been a call for caution regarding unexpected pet behavior leading to fire accidents.

Seven-Eleven have extended the expiry date of its hand-rolled onigiri (rice balls), including salmon, plum, kelp, spicy cod roe, and tuna mayonnaise varieties.

The Japanese government finalized a new strategy on Wednesday aimed at the development of next-generation domestic aircraft, including initiatives for eco-friendly aviation technologies.

FOLLOW US